Testicular Neoplasms
Information
- Disease name
- Testicular Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03426865 | Active, not recruiting | Role of Axumin PET Scan in Germ Cell Tumor | March 1, 2018 | July 5, 2024 | |
| NCT00123773 | Completed | Phase 2 | Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence | April 2004 | December 2008 |
| NCT00231582 | Completed | Phase 2 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | September 2004 | January 2010 |
| NCT02161692 | Completed | Phase 2 | Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | December 1996 | April 2009 |
| NCT00001270 | Completed | Phase 1 | Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma | June 1991 | March 2000 |
| NCT02459132 | Completed | N/A | High-Intensity Aerobic Interval Training in Testicular Cancer Survivors | July 2015 | April 2017 |
| NCT02890030 | Completed | The Platinum Study Comparison Group | May 2015 | June 14, 2017 | |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT03403777 | Completed | Phase 2 | Avelumab in Refractory Testicular Germ Cell Cancer. | November 15, 2017 | February 28, 2019 |
| NCT04122430 | Completed | Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours | December 2015 | October 16, 2020 | |
| NCT05056688 | Completed | N/A | Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors | April 30, 2021 | September 28, 2022 |
| NCT06309732 | Completed | Phase 2 | GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) | July 2006 | January 2014 |
| NCT02229916 | Recruiting | Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS | December 2013 | December 2033 | |
| NCT02341989 | Recruiting | Phase 3 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | April 8, 2015 | December 2035 |
| NCT05264337 | Recruiting | Lymphedema After Urologic Surgery | March 14, 2022 | January 2030 | |
| NCT02577172 | Terminated | N/A | Testicular Cancer and Aerobic and Strength Training | November 2015 | November 2016 |
| NCT02900248 | Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice | October 2, 2017 | March 29, 2019 | |
| NCT02499952 | Terminated | Phase 2 | Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors | January 2016 | January 13, 2017 |
| NCT05229900 | Terminated | Phase 1 | A Study of SGN-ALPV in Advanced Solid Tumors | April 21, 2022 | December 13, 2023 |
| NCT02304575 | Unknown status | Quality of Life Among Testicular Cancer Survivors | January 2015 | November 2018 | |
| NCT02492360 | Withdrawn | Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy | December 2017 | December 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013736